This session covered key approaches in the management of pancreatic neuroendocrine tumours (Pan-NETs). Leading experts in the field reviewed the latest updates in the treatment landscape and defined the role of chemotherapy in the therapeutic strategy. Additionally, two real-world clinical cases were analysed, and the optimal sequencing of therapies in this complex disease was discussed.

This webinar is free and open only to healthcare professionals. If you missed the event, the recording is now available, enjoy it!

Welcome and brief introduction
Dr. Jaume Capdevila

Treatment overview of Pan-NETs

What’s new in the Pan-NETs treatment landscape 
Prof. Marianne Pavel 

The role of chemotherapy in the therapeutic strategy for Pan-NETs
Dr. Jaume Capdevila

Clinical practice sharing 

Defining Patient Profile for First-Line Chemotherapy Treatment 
Prof. Marianne Pavel 

Therapeutic sequencing case in Pan-NETs
Dr. Jaume Capdevila

Interactive Panel
Q&A with audience participation

Dr. Jaume Capdevila:

Medical Oncologist and Senior Researcher at the Vall d'Hebron Institute of Oncology (VHIO) of Barcelona, Spain. With a research portfolio including over 80 publications and active involvement in leading national and international trials, he is a notable figure in the oncology community. Dr. Capdevila chairs the Spanish Neuroendocrine Tumour Group (GETNE) and serves on the Advisory Board of ENETS.

Prof. Marianne Pavel:

Senior Physician and Chair of Endocrinology at the Friedrich-Alexander-University of Erlangen, Germany. A leading figure in the field for over 20 years, contributing significantly to critical clinical guidelines and research, co-authoring the ESMO Clinical Practice Guidelines and ENETS Consensus Guidelines for neuroendocrine neoplasms, and holding the position of member of the ENETS Advisory Board and Chair of ENETS from 2020-2022.

Content included in this program has been developed by Medscape with support from ESTEVE. ESTEVE suggested the topic and author, who was paid an honorarium. No part of this webinar may be reproduced in any form without the permission of the publisher. The views and opinions expressed are not necessarily those of Medscape, its publisher, advisers, or advertisers.

This medical webinar may include data/information on investigational uses of compounds/drugs that have not been approved yet by the regulatory authorities in your country.

The information contained in this webinar is confidential and shared solely for the purpose of this meeting. The information or any portion thereof shall not be communicated, disseminated, reproduced, disclosed or in any way distributed to third parties or used for a different purpose without the prior written consent of Esteve Pharmaceuticals, S.A.